Class 1. Pulmonary Hypertension Associated with Connective Tissue Disease

Development of a PET/MRI exercise stress test for determining cardiac glucose dependence in pulmonary arterial hypertension

Gregory P. Barton, Philip A. Corrado, Christopher J. Francois, James R. Runo, Naomi C. Chesler, Alan B. McMillan, Oliver Wieben, Kara N. GossUniversity of Wisconsin. University of Texas Southwestern Medical Center. University of California-Irvine. United States Pulmonary CirculationPulm Circ 2022; DOI: 10.1002/pul2.12025 AbstractNo Abstract Available CategoryClass I. Pulmonary Hypertension Associated with Connective Tissue DiseasePulmonary Hypertension Associated […]

Development of a PET/MRI exercise stress test for determining cardiac glucose dependence in pulmonary arterial hypertension Read More »

Non-criteria antiphospholipid antibodies and pediatric rheumatic disease: a case series

Shawn A. Mahmud, Danielle R. Bullock, Colleen K. Correll, Patricia M. Hobday, Mona M. Riskalla, Richard K. Vehe, Bryce A. BinstadtUniversity of Minnesota. United States Pediatric RheumatologyPediatr Rheumatol 2022; 20: DOI: 10.1186/s12969-022-00732-4 AbstractBackground: Non-criteria antiphospholipid antibodies (NC-aPL) are a relatively undefined subgroup of antiphospholipid antibodies (aPL). Knowledge about NC-aPL in adults is limited and even less is

Non-criteria antiphospholipid antibodies and pediatric rheumatic disease: a case series Read More »

Pulmonary veno-occlusive disease: two children with gradual disease progression

Ronald W. Day, Parker W. Clement, Aimee O. Hersh, Susan M. Connors, Kelli L. Sumner, D. Hunter Best, Mouied AlashariUniversity of Utah and Primary Children’s HospitalUnited States Respiratory Medicine Case ReportsRespir Med Case Rep 2017; 20: 82-86DOI: 10.1016/j.rmcr.2016.12.007 AbstractPulmonary veno-occlusive disease and pulmonary capillary hemangiomatosis are rare forms of pulmonary vascular disease. We report two cases

Pulmonary veno-occlusive disease: two children with gradual disease progression Read More »

Scroll to Top